Tamarack Advisers as of June 30, 2016
Portfolio Holdings for Tamarack Advisers
Tamarack Advisers holds 28 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Endologix | 13.9 | $36M | 2.9M | 12.46 | |
| NxStage Medical | 10.0 | $26M | 1.2M | 21.68 | |
| Imprivata | 7.0 | $18M | 1.3M | 14.00 | |
| Ariad Pharmaceuticals | 6.0 | $16M | 2.1M | 7.39 | |
| Quest Diagnostics Incorporated (DGX) | 5.7 | $15M | 184k | 81.41 | |
| Medtronic | 5.6 | $15M | 169k | 86.77 | |
| Spectranetics Corporation | 5.1 | $13M | 714k | 18.71 | |
| Allscripts Healthcare Solutions (MDRX) | 4.9 | $13M | 1.0M | 12.70 | |
| Steris Corporation | 4.9 | $13M | 185k | 68.75 | |
| Hologic (HOLX) | 4.5 | $12M | 335k | 34.60 | |
| Luminex Corporation | 4.1 | $11M | 526k | 20.23 | |
| Alkermes (ALKS) | 3.9 | $10M | 233k | 43.22 | |
| Bio-Rad Laboratories (BIO) | 3.8 | $10M | 70k | 143.01 | |
| Laboratory Corp. of America Holdings (LH) | 3.8 | $9.8M | 75k | 130.27 | |
| Pacira Pharmaceuticals (PCRX) | 2.5 | $6.4M | 190k | 33.73 | |
| Nevro (NVRO) | 2.3 | $6.1M | 82k | 73.76 | |
| Dex (DXCM) | 2.0 | $5.2M | 65k | 79.32 | |
| AtriCure (ATRC) | 1.8 | $4.7M | 336k | 14.13 | |
| Amarin Corporation (AMRN) | 1.5 | $3.9M | 1.8M | 2.16 | |
| Sagent Pharmaceuticals | 1.5 | $3.9M | 259k | 14.98 | |
| Corium Intl | 1.4 | $3.7M | 1.1M | 3.47 | |
| Patterson Companies (PDCO) | 1.1 | $2.9M | 4.8k | 600.00 | |
| Endologix, Inc. 3.25% 11/01/2020 | 1.0 | $2.6M | 2.0M | 1.31 | |
| Relypsa | 0.7 | $1.7M | 95k | 18.50 | |
| Streamline Health Solutions (STRM) | 0.5 | $1.4M | 1.1M | 1.20 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.4 | $1.1M | 95k | 11.85 | |
| Model N (MODN) | 0.1 | $267k | 20k | 13.35 | |
| Spdr S&p 500 Etf (SPY) | 0.1 | $123k | 3.0k | 41.00 |
